Skip to main content
S&P 5007,757.37+0.45%DOW51,127.77-0.10%NASDAQ27,387.26+0.72%BTC$85,504.00+0.22%ETH$2,702.80+0.13%GOLD$4,164.80+0.06%OIL$91.23+0.13%
Smart Investors Daily
SID Premium
Balchem Corporation logo

NASDAQ · BCPC

Balchem Corporation

Basic Materials · Chemicals - Specialty

$166.56

Down-$0.62 (-0.37%)

Updated Oct 5, 2026, 3:34 PM

SID Score

4.7/10

Composite research score

Smart Money

58/100

Neutral

Market cap
5.09B
P/E ratio
34.44
Dividend yield
0.52%
52-week range
$139.17 – $183.90
Volume
197.32K
Avg. volume
172.4K

Price performance · BCPC

BCPC price history

1M range · 19 trading sessions · Daily adjusted prices

Prices through Oct 2, 2026

BCPC closed at $166.56 after 19 trading sessions, down 2.35% for the selected period.

Last close
$166.56
Period change
-2.35%
Period low
$163.69
Period high
$170.56
Daily close
View OHLC price history
BCPC OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 2, 2026$165.13$167.18$163.85$166.56197.32K
Oct 1, 2026$163.77$164.44$161.0501$163.69252.58K
Sep 30, 2026$167.66$167.85$164.95$164.96181.06K
Sep 29, 2026$167.49$168.70$165.41$167.15234.68K
Sep 28, 2026$167.89$168.77$166.10$168.68172.55K
Sep 25, 2026$167.41$168.59$166.01$167.89212.52K
Sep 24, 2026$168.94$169.16$166.91$167.84159.37K
Sep 23, 2026$167.65$169.51$167.65$168.24145.64K
Sep 22, 2026$169.58$170.62$167.99$168.40216.99K
Sep 21, 2026$167.73$168.34$166.08$167.34198.97K
Sep 18, 2026$165.35$167.14$164.15$167.05620.24K
Sep 17, 2026$168.88$168.88$165.24$165.76250.22K
Sep 16, 2026$165.59$170.37$165.59$167.60240.12K
Sep 15, 2026$167.08$167.71$163.89$165.27278.15K
Sep 14, 2026$165.58$168.18$164.96$166.83376.9K
Sep 11, 2026$168.85$168.91$164.16$164.39250.64K
Sep 10, 2026$167.55$167.88$165.125$166.67127.77K
Sep 9, 2026$169.94$170.62$167.945$168.34121.66K
Sep 8, 2026$170.44$171.27$169.04$170.56138.26K

Latest BCPC news

The latest Smart Investors Daily articles mentioning BCPC.

Stock researchCompany · Overview

BCPC research

Overview

Company profile and research snapshot.

Company profile

Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$175.50
Implied upside
—
Analysts
—
BCPC recent ratings
DateFirmRatingTarget
Aug 3, 2026HC Wainwright & Co.Buy—
May 4, 2026HC Wainwright & Co.Buy—
Feb 24, 2026HC Wainwright & Co.Buy—
Dec 5, 2025Rothschild & CoNeutral—
Oct 22, 2025HC Wainwright & Co.Buy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 1, 2026

Vitamin K2 Market Forecasts Growth from $179.0M (2026) to $339.9M by 2031, Profiling Gnosis by Lesaffre, Balchem, J-OIL MILLS & Novonesis

The global Vitamin K2 market is projected to grow from USD 179.0 million in 2026 to USD 339.9 million by 2031, registering a 13.7% CAGR. Growth is driven by rising demand for bone and cardiovascular health supplements, preventive healthcare, functional nutrition, and clean-label ingredients. MK-7 is expected to dominate due to its high bioavailability, while pharmaceuticals offer significant growth potential. Asia Pacific will be the fastest-growing region, supported by aging populations and e-c

Yahoo · Sep 25, 2026

Balchem (BCPC) Stock Looks Below Fair Value At Today’s Price

Balchem has delivered a 35.5% return over the past 3 years, which naturally prompts the question of whether the current share price is well supported by the cash the business can generate. With the stock recently closing at US$167.84, the gap between the recent share-price path and the underlying cash flows is what matters most for investors now. The 35.5% return over 3 years highlights the importance of assessing whether Balchem's current market value aligns with the cash it is expected to...

Yahoo · Sep 9, 2026

Balchem Corporation to Participate in the 9th Annual Wells Fargo Consumer Conference on September 23, 2026

MONTVALE, N.J., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the 9th Annual Wells Fargo Consumer Conference on September 23, 2026. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer and Allison Baurichter, Senior Director Investor Relations will participate in the conference. About Balchem Corpor

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By